Research output per year
Research output per year
Personal profile
Research interests
The focus of my laboratory is to utilize genomic information from human sarcoma samples to better understand the development and progression of these cancers in order to identify biomarkers and new therapeutic targets.
Areas of Clinical Interest
Medical oncology, cancer, sarcoma
Fingerprint
Dive into the research topics where Angela Hirbe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
Agulnik, M., Schulte, B., Robinson, S., Hirbe, A. C., Kozak, K., Chawla, S. P., Attia, S., Rademaker, A., Zhang, H., Abbinanti, S., Cehic, R., Monga, V., Milhem, M., Okuno, S. & Van Tine, B. A., Sep 2021, In: European Journal of Cancer. 154, p. 201-208 8 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
Manji, G. A., van Tine, B. A., Lee, S. M., Raufi, A. G., Pellicciotta, I., Hirbe, A. C., Pradhan, J., Chen, A., Rabadan, R. & Schwartz, G. K., Oct 15 2021, In: Clinical Cancer Research. 27, 20, p. 5519-5527 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Chromosome 8 gain is associated with high-grade transformation in MPNST
Dehner, C., Moon, C. I., Zhang, X., Zhou, Z., Miller, C., Xu, H., Wan, X., Yang, K., Mashl, J., Gosline, S. J. C., Wang, Y., Zhang, X., Godec, A., Jones, P. A., Dahiya, S., Bhatia, H., Primeau, T., Li, S., Pollard, K., Rodriguez, F. J. & 4 others, , Mar 22 2021, In: JCI Insight. 6, 6, e146351.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Genetic characterization, current model systems and prognostic stratification in pax fusion-negative vs. Pax fusion-positive rhabdomyosarcoma
Dehner, C. A., Armstrong, A. E., Yohe, M., Shern, J. F. & Hirbe, A. C., Oct 2021, In: Genes. 12, 10, 1500.Research output: Contribution to journal › Review article › peer-review
Open Access -
Interim analysis of the phase II study: Noninferiority study of doxorubicin with upfront dexrazoxane plus olaratumab for advanced or metastatic soft-tissue Sarcoma A C
van Tine, B. A., Hirbe, A. C., Oppelt, P., Frith, A. E., Rathore, R., Mitchell, J. D., Wan, F., Berry, S., Landeau, M., Heberton, G. A., Gorcsan, J., Huntjens, P. R., Soyama, Y., Vader, J. M., Alvarez-Cardona, J. A., Zhang, K. W., Lenihan, D. J. & Krone, R. J., Jul 15 2021, In: Clinical Cancer Research. 27, 14, p. 3854-3860 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations